Elicio Therapeutics Inc. (ELTX) — Financial Flexibility Index
Elicio Therapeutics Inc. (ELTX) has a Financial Flexibility Index of -0.28x as of December 2025. Free cash flow of $-6.78 Million (operating CF $-6.80 Million minus capex $16.00K) represents 0% of total liabilities ($24.23 Million). Also explore net asset momentum of Elicio Therapeutics Inc. to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Elicio Therapeutics Inc. Financial Flexibility Index (2012–2025)
Historical Financial Flexibility Index trend for Elicio Therapeutics Inc. across 10 annual periods. Check Elicio Therapeutics Inc. PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Elicio Therapeutics Inc. (2012–2025)
Year-by-year free cash flow to debt coverage for Elicio Therapeutics Inc.. For the full company profile including market capitalisation, see market cap of Elicio Therapeutics Inc..
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.52x | $-36.94 Million | $-36.95 Million | $24.23 Million | ▼ -62.8% |
| 2024 | -0.94x | $-36.98 Million | $-37.07 Million | $39.49 Million | ▲ +54.7% |
| 2023 | -2.07x | $-32.63 Million | $-32.69 Million | $15.77 Million | ▼ -32.1% |
| 2022 | -1.57x | $-21.52 Million | $-22.18 Million | $13.75 Million | ▼ -0.3% |
| 2021 | -1.56x | $-23.41 Million | $-23.94 Million | $15.01 Million | ▼ -841.0% |
| 2020 | -0.17x | $-22.85 Million | $-22.89 Million | $137.80 Million | ▲ +79.2% |
| 2019 | -0.80x | $-24.35 Million | $-24.59 Million | $30.47 Million | ▲ +23.1% |
| 2018 | -1.04x | $-8.02 Million | $-8.02 Million | $7.72 Million | ▼ -459.3% |
| 2013 | 0.29x | $1.91 Million | $1.89 Million | $6.60 Million | ▲ +76.5% |
| 2012 | 0.16x | $1.11 Million | $1.07 Million | $6.79 Million | — |